System and method for collecting, storing, processing, transmitting and presenting very low amplitude signals

Inventors

Butters, John T. • Butters, Bennett M. • Naughton, Patrick • Puckette, Miller

Assignees

EMulate Therapeutics Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-9417257-B2

Patent

Publication Date

2016-08-16

Expiration Date


Abstract

A method and apparatus for producing an effect of a chemical or biochemical agent on a system responsive to such agent, are disclosed. In practicing the method, a plurality of low-frequency time-domain signals of the agent are generated, each at a different at a different noise level within a selected noise level range. The signals are analyzed by producing spectral plots of the time-domain signals, and identifying an optimized agent-specific time-domain signal based on information in the spectral plots. A chemical or biological system responsive to the agent is exposed to the optimized time-domain signal by placing the system within the magnetic field of an electromagnetic transducer, and applying the signal to the transducer at a signal amplitude and for a period sufficient to produce in the system an agent-specific effect on the system.

Core Innovation

The invention provides a method for producing an effect of a chemical or biochemical agent on a system by generating a plurality of low-frequency electromagnetic time-domain signals. A sample containing the agent is placed in a container having both magnetic and electromagnetic shielding, noise is injected into the sample at a given noise amplitude, and an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise is recorded. The injecting and recording are repeated at a plurality of noise levels within a selected noise-level range.

The recorded time-domain signals are analyzed by producing spectral plots and identifying an agent-specific time-domain signal based on information in the spectral plots. In the analyzing, a histogram is generated over a selected frequency range within DC to 8 kHz to assign a score related to the number of bins above a given threshold, or autocorrelation is performed followed by an FFT over DC to 8 kHz to assign a score related to the number of peaks above a mean average noise value, or a series of Fourier spectra over defined time periods is calculated and averaged, with a score related to the number of peaks above a mean average noise value used to select the agent-specific time-domain signal.

The method then exposes an agent-responsive system to the selected agent-specific time-domain signal by placing the system within the magnetic field of an electromagnetic transducer and applying the identified signal at a signal amplitude and for a period sufficient to produce an agent-specific effect on the system. The approach further includes treating a tumor in a mammalian subject by generating analogous agent-specific time-domain signals from a cancer chemotherapeutic agent sample and applying the selected agent-specific time-domain signal with an electromagnetic transducer for a period sufficient to reduce tumor size and/or rate of growth.

Claims Coverage

The partial content includes two independent claims: clm-00001 and clm-00016. Both independent claims share the same core inventive workflow: generate low-frequency electromagnetic time-domain signals by injecting noise into a shielded sample across noise levels, analyze spectral plots to identify an agent-specific time-domain signal using defined scoring, and expose a target system using an electromagnetic transducer to produce a corresponding effect.

Agent-specific time-domain signal generation from a shielded noisy sample

Generating a plurality of low-frequency time-domain signals by placing a sample containing the chemical or biochemical agent in a container having both magnetic and electromagnetic shielding, injecting noise into the sample at a given noise amplitude, recording an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise, and repeating the injecting and recording at a plurality of noise levels within a selected noise-level range.

Spectral-plot based identification using histogram or peak scoring

Analyzing the plurality of time domain signals by producing spectral plots of the plurality of time-domain signals and identifying an agent-specific time-domain signal based on information in said spectral plots, wherein the analyzing includes generating a histogram with a score related to the number of bins above a given threshold and selecting based on said score, or autocorrelating and generating an FFT with a score related to the number of peaks above a mean average noise value and selecting based on said score, or calculating and averaging a series of Fourier spectra over defined time periods with a score related to the number of peaks above a mean average noise value and selecting based on said score.

Transducer-based exposure of the agent-responsive system

Exposing the agent-responsive system to the agent-specific time-domain signal identified in the analyzing by placing the system within the magnetic field of an electromagnetic transducer and applying said agent-specific time-domain signal to said electromagnetic transducer at a signal amplitude and for a period associated with the chemical or biochemical agent sufficient to produce in the system an agent-specific effect on the system.

Tumor treatment via transducer exposure to a chemotherapeutic agent-specific signal

Treating a tumor in a mammalian subject by generating a plurality of low-frequency time-domain signals from a sample containing a cancer chemotherapeutic agent with magnetic and electromagnetic shielding and injected noise across a selected range, analyzing recorded signals by producing spectral plots to identify an agent-specific time-domain signal, and exposing the mammalian subject to that signal by placing the subject within the magnetic field of an electromagnetic transducer and applying said agent-specific time-domain signal at an amplitude and for a period sufficient to produce a reduction in the size and/or rate of growth of a tumor in the subject.

Across both independent claims, the inventive concept is the selection of an agent-specific low-frequency electromagnetic time-domain signal from noisy, shielded sample recordings using spectral plot scoring, followed by applying the selected signal through an electromagnetic transducer to produce an agent-specific effect or to reduce tumor size and/or growth rate.

Stated Advantages

Producing an agent-specific effect in the system.

Reduction in the size and/or rate of growth of a tumor in a mammalian subject.

Documented Applications

Inducing a lac-operon response in an E. coli target, where resulting peaks correspond to frequencies of stochastic events produced by arabinose L(+).

Increasing binding or assembly between components to a level greater than that observed prior to exposure.

Inhibiting pea sprout stem growth by glyphosate.

Stimulation of a response by gibberellic acid.

Inhibition of 20S proteasome activity by phepropeptin D.

Tumor growth inhibition in a mouse xenograft model using taxol.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.